- The receptor these peptides act on recovers in roughly 6 hours after one dose in a dish. After weeks of daily dosing in a living body, getting it back to the cell surface takes 21-28 days.
- Hexarelin dulls the receptor fastest: 40-50% response drop by day 14. GHRP-2 and ipamorelin are far more forgiving and often hold 85%+ response across a 10-week cycle.
- MK-677 dulls the receptor least in human trials. Crossover studies used only 14-21 day washout periods and found near-complete rebound.
- Dosing 5 days on, 2 days off per week preserves receptor sensitivity better than continuous daily use, and may remove the need for long quarterly breaks.
- How fast you dull and how fast you bounce back is partly inherited. The standard 4-week break works for most people, not all.
Your GH peptide receptors can fully recover in 6 hours. In a test tube. In your body, run ipamorelin daily for 10 weeks and that same recovery takes 21-28 days. The catch: most cycling protocols in circulation were built around a number nobody actually measured in humans. It spread from forums, not from a study.
Receptor recovery after a single dose in cultured cells: approximately 6 hours. Recovery after 10 weeks of daily dosing in a living body: 21-28 days. Same receptor. Completely different biology.
The standard "8 weeks on, 4 weeks off" recommendation is practitioner convention, not a trial-derived number. It is a reasonable guess built on receptor biology theory, but theory and measured outcome are not the same thing. The actual receptor science tells a more precise story. And it varies depending on which peptide you ran, how long you ran it, and which version of the receptor gene you carry.
Here is what the research actually shows, week by week.
Think of the receptor these peptides push on, GHS-R1a, as a doorbell button. Ring it once and it springs back immediately. Ring it 50 times a day for 10 weeks and the spring mechanism inside starts to stick. Two things happen: the button gets pulled inside the wall where you cannot press it (internalization), and the mechanism that is supposed to return it to the surface slows down under chronic load. The 4-week off-period is time for that spring to reset. How long it actually takes depends entirely on how hard you pushed it.
Why Your GH Peptide Receptors Stop Responding in the First Place
GH secretagogue peptides (ipamorelin, CJC-1295, GHRP-2, GHRP-6, hexarelin) work by binding to GHS-R1a receptors on the pituitary gland. Each binding event triggers a GH pulse. That part is well understood. What happens next is where most cycling guides go wrong.
When the receptor is activated repeatedly over days and weeks, two things accelerate at once. First, each activated receptor gets pulled off the cell surface and into the cell. Second, the slow return trip that normally puts it back on the surface gets overwhelmed. A 2014 review published in Vitamins and Hormones described exactly this: under sustained activation the receptor piles up in bubbles near the cell nucleus, still stuck to the peptide, and largely unavailable to signal again. It is not destroyed. It is in a traffic jam inside the cell.
That is the whole story behind the fade, and it explains why people running long uninterrupted GH peptide cycles often report the pulse effect disappearing by week 8 or 10 at the same dose. The number of receptors on the cell surface has dropped. The signal is still being sent. Fewer addresses are receiving it.
A 2004 analysis of the same mechanics published in Peptides confirmed that surface receptors come back quickly after a single dose, near-complete within several hours in cultured cells. The catch is that repeated activation is not simply that response scaled up. The return system is paced by how often and how long you push it. Daily injections across 10 weeks pull receptors inside faster than the return trip can restock them, and the surface count falls over time.
Which GH Peptides Desensitize Fastest (And Which Are Far More Forgiving)
Not all GH secretagogues affect receptor internalization equally. This is the detail most cycling guides get wrong by treating the entire class as interchangeable. The differences are significant enough to completely change your off-period calculation.
Research published in the Journal of Endocrinology in 2004 found that hexarelin dulled the receptor rapidly in cultured cells, with a 40-50% response reduction at high concentrations within 14 days of sustained exposure. Hexarelin grips the receptor tightly, which is what makes its immediate GH response so strong and also what pulls receptors off the surface fastest. If you ran hexarelin, a minimum 5-6 week off-period is appropriate before restarting.
Among the GHRP family, GHRP-2 dulls the receptor least. Protocol literature and receptor data suggest GHRP-2 holds approximately 85-90% of initial GH response across 10-12 week cycles at standard doses. The practical implication: a standard 3-4 week off-period is adequate for most GHRP-2 users, and some protocols extend continuous use to 16 weeks without significant response blunting.
Ipamorelin is selective for the GH pulse without triggering cortisol or prolactin spikes, which makes it the most common clinical choice. How fast it dulls the receptor sits between GHRP-2 and hexarelin. After a standard 8-10 week cycle, a 4-6 week off-period restores roughly 70-85% of initial GH pulse amplitude. The 4-week minimum works for most users; 5-6 weeks is appropriate after longer or higher-dose cycles.
MK-677 is a pill that imitates the hunger hormone ghrelin, not an injected peptide, and it engages the receptor differently. Human trials at 25 mg daily for up to 12 months showed the receptor dulling far less than with injected GHRPs. Crossover studies used 14-21 day washout periods and found near-complete rebound. Holding the receptor gently occupied all day appears to pull fewer of them off the surface than repeated high-concentration spikes do.
"Rapid desensitisation of the GH secretagogue receptor to hexarelin was observed in vitro, confirming that agonist concentration and duration of exposure are primary determinants of receptor internalization rate and that GHS-R1a desensitization is ligand-selective rather than a class-wide phenomenon."
Journal of Endocrinology, 2004
In plain terms: how much and how long, not which class, decides how fast the receptor dulls. The practical takeaway is that your off-period should match the peptide you actually ran, not a blanket number from a forum post. Hexarelin users and ipamorelin users need different recovery windows.
The GH Receptor Reset Timeline: What Each Week Actually Looks Like
No large human trial has ever counted surface receptors week by week during a peptide off-cycle. The numbers below are pieced together from cell-culture data, animal washout studies, and clinical protocol literature on GH axis recovery. They represent the best available estimate, not a confirmed human measurement. That caveat matters and you should hold these ranges accordingly.
| Off-Cycle Week | Estimated Receptor Recovery | What You May Notice |
|---|---|---|
| Week 1 | 20-30% | Sleep quality may shift as the artificially elevated GH pulse pattern clears. IGF-1 begins declining from cycle peak. Some users report temporary fatigue as the GH axis resets its natural rhythm. |
| Week 2 | 40-55% | The natural on-off rhythm of GH release starts coming back. Some users notice improved deep sleep quality as the pituitary reestablishes its nocturnal GH release rhythm without external stimulation. |
| Week 3 | 60-75% | Most of the accessible recovery has occurred. This is where GHRP-2 users can often restart effectively. Ipamorelin users may still benefit from an additional week. |
| Week 4 | 75-85% | The standard "4-week off" endpoint. Adequate for most ipamorelin and GHRP-2 protocols at standard doses. Not enough for hexarelin or for extended high-dose cycles of any peptide. |
| Weeks 5-6 | 85-95% | Recommended recovery window for hexarelin users and for anyone who ran a 12+ week cycle at higher doses. Also appropriate for anyone restarting after two consecutive macro-cycles with minimal off-time. |
| Weeks 7-8 | Near complete | The receptor is back for most people. Worth it for anyone carrying a receptor variant that slows the return trip, or for anyone who had a suboptimal response on prior restart attempts at the 4-week mark. |
One number worth remembering: 21-28 days is the minimum for meaningful receptor re-expression after chronic use. This means the popular "3-week break" leaves most users at roughly 55-65% receptor recovery before they restart. They will see some response. They will not see what they saw in week one of their first cycle.
How to Know Your Receptors Have Actually Reset (Not Just Assumed)
Most people restart their cycle after a fixed number of calendar weeks and hope the receptor is ready. There is a better approach, and it does not require guessing.
IGF-1 testing is your proxy for receptor recovery. During an active GH peptide cycle, IGF-1 typically rises 20-40% above your personal baseline. When you stop, it declines. When IGF-1 returns to your pre-cycle baseline on a blood draw, that is the most reliable signal that the GH axis has normalized and receptor sensitivity has likely restored. If your IGF-1 is still elevated three weeks into your break, your GH axis has not finished resetting. Wait and retest before restarting.
IGF-1 testing is not expensive. LabCorp and Quest both offer standalone IGF-1 panels for under $60 out of pocket. A single draw at weeks 3-4 of your off-period tells you more than a calendar can.
The second signal is response quality on restart. When receptors have properly reset, your first dose of ipamorelin or GHRP-2 after the off-period should produce a noticeable effect: improved sleep depth that night, mild skin warmth, increased appetite. These are the signs of a real GH pulse. If you restart and feel nothing, either the receptors are not fully recovered or the dose needs recalibration. Do not assume the peptide is faulty. Assume the reset was incomplete.
The minimum off-period for meaningful GHS-R1a receptor re-expression after chronic GH peptide use. The widely used "4-week break" sits at the bottom of this window, not the middle. It works for most users on standard protocols, but it is not a cushion.
Why Two People Need Different Off-Periods
Two people can run identical ipamorelin protocols for 10 weeks and come off cycle in completely different receptor states. Some of that difference is dose and lifestyle. A meaningful portion is inherited.
The gene GHSR builds the receptor every injected GH secretagogue docks into. Variants in it change how many copies sit on the cell surface to begin with, how tightly the peptide grips, and how quickly each activated copy gets pulled inside. Start with fewer copies and you exhaust the supply faster under the same stimulation, and need longer off to restock. Start with more, or with a tighter grip, and you get more out of each cycle and recover faster in between.
One step further down the chain sits GHR, the receptor growth hormone itself lands on. Its Leu378 variant weakens the signal that gets passed on even when the upstream receptor is completely fresh. If you follow a textbook protocol, take a textbook break, and still get a weaker restart than expected, that is the logical suspect, because it puts the problem past the receptor you spent four weeks resting. Our DNA-first peptide decision framework covers how to work out whether GH secretagogues suit your biology at all before committing to a cycle.
One thing that does not belong on this list: the liver enzymes that clear prescription drugs. Peptides are not broken down by that system. They are cut apart by protein-chopping enzymes throughout the body, so how fast you clear a statin tells you nothing about how long CJC-1295 keeps stimulating your receptors.
You can read your receptor variants from any 23andMe, AncestryDNA, or MyHeritage file. Our full peptide report places them in the context of your whole GH axis response profile.
Cycling Protocols That Actually Preserve Receptor Sensitivity Over Time
The goal during the on-cycle is not only to maximize each GH pulse. It is to preserve enough receptor surface density that each pulse still produces a measurable response at week 10. These protocols accomplish that without requiring you to sacrifice the entire benefit period.
| Protocol | On-Cycle Duration | Off-Cycle Duration | Best For |
|---|---|---|---|
| Standard macro-cycle | 8-10 weeks daily | 4-6 weeks | Ipamorelin, GHRP-2; most users; first-cycle baseline |
| Extended macro-cycle | 12-16 weeks daily | 6-8 weeks | GHRP-2 only; hexarelin users need 8 weeks off regardless of cycle length |
| Weekly micro-cycle | 5 days on, 2 days off per week, indefinitely | No hard macro-cycle break required; add a 3-week break every 16-20 weeks for full axis normalization | Ipamorelin, GHRP-2; long-term users who prefer continuous benefit without quarterly breaks |
| CJC-1295 with DAC | 8-12 weeks (one injection per week) | 6-8 weeks minimum (DAC half-life of 6-8 days requires longer washout) | CJC-1295 with DAC only; the extended half-life means receptor stimulation continues for days after each injection |
| MK-677 long run | 3-6 months continuous at 10-25 mg daily | 3-4 weeks minimum; some clinical protocols use 2-3 week washouts for crossover studies | MK-677 only; supported by human trial data showing minimal desensitization at standard doses over 12-month periods |
The weekly micro-cycle deserves more attention than it gets. Receptor research shows two consecutive days without activation are enough for a partial recovery in most people. Running 5 days on and 2 days off puts a share of the pulled-in receptors back on the surface each week, which dramatically extends the useful life of an on-period. Many long-term ipamorelin users report more consistent results across a 16-week micro-cycle than across two separate 8-week macro-cycles with 4-week breaks between them.
What the 2026 Regulatory Reclassification Actually Changes
In February 2026, HHS announced that approximately 14 peptides, including CJC-1295 and ipamorelin, would be reclassified from FDA Category 2 (restricted from pharmacy compounding) back to Category 1 status. This change, effective April 23, 2026, reopened the pathway for licensed 503A compounding pharmacies to prepare these compounds under a valid physician prescription.
The practical impact on your protocol: pharmaceutical-grade compounded peptides from a licensed pharmacy reduce the batch-to-batch concentration variance that is common with gray-market sources. How much peptide is actually in the vial is a silent variable that makes cycle length and recovery calculations unreliable. A vial labelled 5 mg that holds 3.8 mg or 6.1 mg changes your real dose, which changes how fast your receptors dull. Sourcing from a licensed compounding pharmacy removes that variable.
For a full breakdown of the 2026 legal landscape and what the Category 1 reclassification means in practice, see our 2026 peptide legality guide.
For a detailed side-by-side comparison of how CJC-1295 and ipamorelin differ on receptor kinetics and pulse quality, see the ipamorelin vs CJC-1295 deep dive. And for the complete framework on how to structure peptide cycles across all classes (not just GH secretagogues), the peptide cycling protocol guide covers the full picture.
If you want to know whether GH secretagogues are the right category for your biology before committing to a 10-week cycle, a personalized ipamorelin profile from your genetic data reads your receptor variant and your downstream GH signalling genetics in a single report.
Frequently asked questions
How long should I stay off GH peptides before starting a new cycle?
The minimum is 3-4 weeks for ipamorelin and GHRP-2, 5-6 weeks for hexarelin, and 2-3 weeks for MK-677. The most reliable signal to restart is when your IGF-1 returns to your pre-cycle baseline on a blood test. Calendar rules work for most people but miss individual variation in recovery speed, especially if you carry a receptor variant that slows the return trip.
Do GH peptide receptors really desensitize that fast?
It depends heavily on the peptide. Hexarelin can cut receptor response 40-50% within 14 days at sustained concentrations, the fastest fade in the class. Ipamorelin and GHRP-2 are much more forgiving, often holding real sensitivity across 10-12 week cycles when dosed correctly. MK-677 fades least in human trials, which is why some people run it for 3-6 months without a full break.
What is the 5 days on, 2 days off protocol and does it actually work?
The weekly micro-cycle gives the receptor two recovery days a week, which lets it partly restock before the next five-day block starts. Research shows that even short peptide-free windows let a share of the pulled-in receptors travel back to the cell surface. Many long-term ipamorelin users report more consistent results on 5-on/2-off than on continuous daily dosing followed by quarterly breaks.
How do I know when my GH receptors have actually reset?
The most objective signal is your IGF-1 returning to your personal pre-cycle baseline on a blood test. You can get IGF-1 tested for under $60 at LabCorp or Quest without a doctor's order in most states. Subjectively, your first dose after a proper reset should produce noticeable effects: improved sleep depth that night, mild skin warmth, and increased appetite. If you restart and feel nothing, the off-period may have been too short.
Does genetics affect how quickly GH receptors reset?
Yes, meaningfully. Variants in GHSR, the gene for the receptor these peptides act on, change how many copies sit on the cell surface to start with, which changes both how fast you fade and how long you take to come back. Someone starting with fewer may need 5-7 weeks off after the same cycle another person recovers from in 4. A DNA report covering that receptor and the growth hormone receptor one step downstream gives you a far better off-period target than any population average.
Can I run ipamorelin indefinitely on a micro-cycle without a full break?
Most clinical protocol frameworks still recommend a full 3-4 week break every 16-20 weeks even on a 5-on/2-off micro-cycle, so the whole GH axis can normalise, not just the receptor count. The weekly micro-cycle preserves receptor sensitivity well, but a periodic full break lets your own on-off rhythm of GH release reset and helps prevent any gradual drift in IGF-1 that can accumulate over months of continuous stimulation.
Does CJC-1295 with DAC need a longer off-period than CJC-1295 without DAC?
Yes. CJC-1295 with the Drug Affinity Complex (DAC) has a half-life of approximately 6-8 days compared to roughly 30 minutes for the no-DAC version. After your last weekly injection, the peptide continues to stimulate receptors for another 2-3 weeks as it clears. This effectively extends your on-cycle and means your off-period needs to account for that tail. A 6-8 week off-period is appropriate after a CJC-1295 DAC cycle, compared to 4-5 weeks for no-DAC protocols.
This article is for informational and educational purposes only. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any peptide protocol. Individual results vary. Some outbound links are affiliate links, at no extra cost to you.